I haven’t followed them closely since 2005, when I bought some on the cheap (#msg-5041574).
>I read the panel discussion were positive for them, resulting in a reduction in patient enrollment requirement from 1,600 to 1,000 in the PFO trials.<
I’m not sure which panel you’re referring to. I guess this means I’m even more out of touch than I thought
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.